VINBLASTINA
Información Básica
| Elemento | Valor |
|---|---|
| DrugBank ID | DB00570 |
| Nivel de Evidencia | L5 (Predicción Computacional) |
| Número de Indicaciones Predichas | 28 |
Indicaciones Predichas (TxGNN)
Las siguientes son posibles nuevas indicaciones predichas por el modelo TxGNN. Puntuaciones más altas indican mayor relevancia predicha.
| # | Indicación | Fuente |
|---|---|---|
| 1 | testicular germ cell tumor | TxGNN Knowledge Graph |
| 2 | yolk sac tumor | TxGNN Knowledge Graph |
| 3 | non-Hodgkin lymphoma | TxGNN Knowledge Graph |
| 4 | primary cutaneous T-cell lymphoma | TxGNN Knowledge Graph |
| 5 | mycosis fungoides and variants | TxGNN Knowledge Graph |
| 6 | granulomatous slack skin disease | TxGNN Knowledge Graph |
| 7 | mantle cell lymphoma | TxGNN Knowledge Graph |
| 8 | classic Hodgkin lymphoma | TxGNN Knowledge Graph |
| 9 | lymphosarcoma | TxGNN Knowledge Graph |
| 10 | seminoma | TxGNN Knowledge Graph |
| 11 | female breast carcinoma | TxGNN Knowledge Graph |
| 12 | gestational trophoblastic neoplasm | TxGNN Knowledge Graph |
| 13 | letterer-Siwe disease | TxGNN Knowledge Graph |
| 14 | testicular seminoma | TxGNN Knowledge Graph |
| 15 | lymphoma, non-Hodgkin, familial | TxGNN Knowledge Graph |
| 16 | testicular teratoma | TxGNN Knowledge Graph |
| 17 | obsolete Hodgkin's granuloma | TxGNN Knowledge Graph |
| 18 | folliculotropic mycosis fungoides | TxGNN Knowledge Graph |
| 19 | spermatocytic seminoma | TxGNN Knowledge Graph |
| 20 | B-cell neoplasm | TxGNN Knowledge Graph |
| 21 | Kaposi's sarcoma (disease) | TxGNN Knowledge Graph |
| 22 | Langerhans cell histiocytosis | TxGNN Knowledge Graph |
| 23 | classic Hodgkin lymphoma, lymphocyte-rich type | TxGNN Knowledge Graph |
| 24 | localized pagetoid reticulosis | TxGNN Knowledge Graph |
| 25 | Hodgkin's paragranuloma | TxGNN Knowledge Graph |
| 26 | testicular cancer | TxGNN Knowledge Graph |
| 27 | lymphoma | TxGNN Knowledge Graph |
| 28 | Hodgkins lymphoma | TxGNN Knowledge Graph |
Descargo de Responsabilidad
Estas predicciones son solo para fines de investigación y no constituyen consejo médico. Se requiere validación clínica antes de cualquier aplicación clínica.